MGX vs RHI · rev $25.2M vs P/E 21, rev $5.38B
Metagenomi, Inc. Common Stock (MGX) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
MGX currently screens at market cap $44.4M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the MGX and RHI stock pages for the full models.
Not investment advice.